In Vivo Structure-function Studies of Human Hepatic Lipase: the Catalytic Function Rescues the Lean Phenotype of HL-deficient (hl-/-) Mice

Overview

Journal Physiol Rep

Specialty Physiology

Date 2015 Apr 12

PMID 25862097

Citations 3

Authors

Jeffrey Chen

Karl J Kaiyala

Jennifer Lam

Nalini Agrawal

Lisa Nguyen

Kayoko Ogimoto

Dean Spencer

Gregory J Morton

Michael W Schwartz

Helen L Dichek

Affiliations

Soon will be listed here.

Abstract

The lean body weight phenotype of hepatic lipase (HL)-deficient mice (hl(-/-)) suggests that HL is required for normal weight gain, but the underlying mechanisms are unknown. HL plays a unique role in lipoprotein metabolism performing bridging as well as catalytic functions, either of which could participate in energy homeostasis. To determine if both the catalytic and bridging functions or the catalytic function alone are required for the effect of HL on body weight, we studied (hl(-/-)) mice that transgenically express physiologic levels of human (h)HL (with catalytic and bridging functions) or a catalytically-inactive (ci)HL variant (with bridging function only) in which the catalytic Serine 145 was mutated to Alanine. As expected, HL activity in postheparin plasma was restored to physiologic levels only in hHL-transgenic mice (hl(-/-)hHL). During high-fat diet feeding, hHL-transgenic mice exhibited increased body weight gain and body adiposity relative to hl(-/-)ciHL mice. A similar, albeit less robust effect was observed in female hHL-transgenic relative to hl(-/-)ciHL mice. To delineate the basis for this effect, we determined cumulative food intake and measured energy expenditure using calorimetry. Interestingly, in both genders, food intake was 5-10% higher in hl(-/-)hHL mice relative to hl(-/-)ciHL controls. Similarly, energy expenditure was ~10% lower in HL-transgenic mice after adjusting for differences in total body weight. Our results demonstrate that (1) the catalytic function of HL is required to rescue the lean body weight phenotype of hl(-/-) mice; (2) this effect involves complementary changes in both sides of the energy balance equation; and (3) the bridging function alone is insufficient to rescue the lean phenotype of hl(-/-)ciHL mice.

Citing Articles

Tumor Necrosis Factor Superfamily 14 (LIGHT) Restricts Neovascularization by Decreasing Circulating Endothelial Progenitor Cells and Function.

Hsu C, Huang C, Shih C, Lin Y, Huang P, Lin S Int J Mol Sci. 2023; 24(8).

PMID: 37108160 PMC: 10138919. DOI: 10.3390/ijms24086997.

Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.

Amini S, Gouyer V, Portal C, Gottrand F, Desseyn J Histochem Cell Biol. 2019; 152(2):167-174.

PMID: 31030254 DOI: 10.1007/s00418-019-01785-5.

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.

Cedo L, Santos D, Roglans N, Julve J, Pallares V, Rivas-Urbina A PLoS One. 2017; 12(12):e0189834.

PMID: 29244870 PMC: 5731695. DOI: 10.1371/journal.pone.0189834.

References

Dichek H, Qian K, Agrawal N . Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24(9):1696-702. DOI: 10.1161/01.ATV.0000135981.61827.9d. View

Nguyen D, El-Serag H . The epidemiology of obesity. Gastroenterol Clin North Am. 2010; 39(1):1-7. PMC: 2833287. DOI: 10.1016/j.gtc.2009.12.014. View

Chiu H, Qian K, Ogimoto K, Morton G, Wisse B, Agrawal N . Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis. Endocrinology. 2010; 151(3):993-1001. PMC: 2840680. DOI: 10.1210/en.2009-1100. View

Sanan D, Fan J, Bensadoun A, Taylor J . Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res. 1997; 38(5):1002-13. View

Kaiyala K, Morton G, Leroux B, Ogimoto K, Wisse B, Schwartz M . Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes. 2010; 59(7):1657-66. PMC: 2889765. DOI: 10.2337/db09-1582. View

Ji Z, Dichek H, Miranda R, Mahley R . Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem. 1998; 272(50):31285-92. DOI: 10.1074/jbc.272.50.31285. View

Dichek H, Agrawal N, El Andaloussi N, Qian K . Attenuated corticosterone response to chronic ACTH stimulation in hepatic lipase-deficient mice: evidence for a role for hepatic lipase in adrenal physiology. Am J Physiol Endocrinol Metab. 2005; 290(5):E908-15. DOI: 10.1152/ajpendo.00442.2005. View

Beigneux A, Davies B, Gin P, Weinstein M, Farber E, Qiao X . Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 2007; 5(4):279-91. PMC: 1913910. DOI: 10.1016/j.cmet.2007.02.002. View

Kuusi T, Saarinen P, NIKKILA E . Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980; 36(4):589-93. DOI: 10.1016/0021-9150(80)90251-8. View

10.

Mehrabian M, Wen P, Fisler J, Davis R, Lusis A . Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 1998; 101(11):2485-96. PMC: 508838. DOI: 10.1172/JCI1748. View

11.

Connelly P . The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta. 1999; 286(1-2):243-55. DOI: 10.1016/s0009-8981(99)00105-9. View

12.

Despres J, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien P . Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 1989; 9(4):485-92. DOI: 10.1161/01.atv.9.4.485. View

13.

Sendak R, Berryman D, Gellman G, Melford K, Bensadoun A . Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters. J Lipid Res. 2000; 41(2):260-8. View

14.

Peterson J, Olivecrona T . Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochim Biophys Acta. 1986; 878(1):65-70. DOI: 10.1016/0005-2760(86)90344-9. View

15.

Qian K, Agrawal N, Dichek H . Reduced atherosclerosis in chow-fed mice expressing high levels of a catalytically inactive human hepatic lipase. Atherosclerosis. 2007; 195(1):66-74. DOI: 10.1016/j.atherosclerosis.2006.12.002. View

16.

Carr M, Hokanson J, Deeb S, Purnell J, Mitchell E, Brunzell J . A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol. 1999; 19(11):2701-7. DOI: 10.1161/01.atv.19.11.2701. View

17.

Kaiyala K, Schwartz M . Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes. 2011; 60(1):17-23. PMC: 3012169. DOI: 10.2337/db10-0909. View

18.

U S Department Of Health And Human Services . Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths. J Pain Palliat Care Pharmacother. 2015; 29(2):133-9. DOI: 10.3109/15360288.2015.1037530. View

19.

Kersten S . Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014; 1841(7):919-33. DOI: 10.1016/j.bbalip.2014.03.013. View

20.

Jansen H, Kalkman C, Zonneveld A, Hulsmann W . Secretion of triacylglycerol hydrolase activity by isolated parenchymal rat liver cells. FEBS Lett. 1979; 98(2):299-302. DOI: 10.1016/0014-5793(79)80204-5. View